SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Authorities will also guide local governments to use the subsidies in a balanced and orderly manner and to pace implementation appropriately, according to a statement from the National Development and Reform Commission.</li><li>The move comes as China seeks to boost domestic demand, making it a top economic priority for 2026.</li></ul>China on Tuesday announced the first batch of 62.5 billion yuan ($8.92 billion) in subsidies to support the trade-in of consumer goods for 2026.The National Development and Reform Commission (NDRC) <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251230_1402850.html">said</a> in a statement that the government will sell ultra-long special sovereign bonds to local governments in 2026 to support consumer programs and meet consumption demands during peak seasons such as New Year's Day and the Spring Festival.The NDRC authorities will also guide local governments to use the subsidies in a balanced and orderly manner, pace implementation appropriately, and strengthen fund supervision throughout the entire chain to maximize the policy's impact, it added.<h2 class="st-heading-2">Bolstering Domestic Demand</h2>China is looking to boost domestic demand and has made it a top economic priority for 2026.According to an earlier report from Bloomberg, the Politburo, the Communist Party’s decision-making arm led by President Xi Jinping, noted that domestic demand must be a primary driver for a strong market in its December meeting.The move to boost domestic demand comes amid an economic slowdown over the past year, driven by weakening domestic demand, declining investment, sluggish industrial output, and deflationary pressures. Chinese households have also cut back on their spending due to a soft labor market and pressures in the real estate industry. The U.S. tariffs have also prompted the country’s senior leaders to increase China’s self-reliance in multiple industries.<h2 class="st-heading-2">Future Outlook</h2>While the Chinese economy has clocked a year-to-date GDP growth of 5.2% year-on-year as of December, it is projected to grow only 4.4% in 2026, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.worldbank.org/en/news/press-release/2025/12/11/advancing-reforms-can-enhance-prospects-china-economic-update">report</a> from the World Bank. It expects the existing headwinds to persist next year as well.The <a href="https://stocktwits.com/symbol/CHIS">Global X MSCI China Consumer Staples ETF</a> (CHIS), which tracks Chinese consumer stocks, has declined by more than 34% over the last year. Meanwhile, the <a href="https://stocktwits.com/symbol/IYK">iShares U.S. Consumer Staples ETF</a> (IYK), which tracks U.S. consumer stocks, has climbed more than 3% over the same period.The <a href="https://stocktwits.com/symbol/XLP">Consumer Staples Select Sector SPDR Fund</a> (XLP) declined marginally by 0.11% in the past year, while the <a href="https://stocktwits.com/symbol/VDC">Vanguard Consumer Staples ETF</a> (VDC) was up by 0.03% in the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.(1 Chinese Yuan = $0.14)&nbsp; &nbsp;

 Generic lady in a long skirt sitting at a bus stop with her shopping in paper bags as Autumn leaves pass her by, 18 March 2002. AFR Picture by ERIN JONASSON (Photo by Fairfax Media via Getty Images via Getty Images)

China Announces First Tranche Of Nearly $9 Billion In Consumer Subsidies For 2026

The government will sell ultra-long special sovereign bonds worth 62.5 billion yuan to local governments in 2026 to meet consumption demands during peak seasons. 

Equity

The government will sell ultra-long special sovereign bonds worth 62.5 billion yuan to local governments in 2026 to meet consumption demands during peak seasons.


 Consumer Staple ETFs to Watch Amid Persistent Inflation Concerns

Amid inflation and consumer trade-down trends, XLP emerges as a defensive ETF for stability-focused investors.  

<ul class="summary-bullets"><li>Analysts expect Walmart to report a 4.3% increase in sales and a 3.7% rise in adjusted EPS for the third quarter, with some expecting a slight upward revision to the annual forecast.</li><li>Some brokerages highlight support from Walmart’s digital initiatives, including a greater push in digital advertising and e-commerce.</li><li>Stocktwits sentiment for WMT shifted to ‘bullish’ from ‘bearish’ heading into Thursday; Walmart will report results in premarket hours.</li></ul>Walmart Inc. is expected to deliver steady results for its recently completed fiscal third quarter, with guidance for the crucial holiday period in sharp focus for analysts and investors.&nbsp;The nation’s largest retailer has navigated a turbulent period of inflation and shifting consumer behavior by keeping prices tight and leveraging its dominant position in essentials like groceries.Notably, Walmart had raised its full-year sales and profit forecast in August, forecasting net sales growth of 3.75% to 4.75% and adjusted earnings per share (EPS) of $2.52 to $2.62 for its current fiscal year, which ends in January 2026.Walmart is likely to post a clean Q3 print on stability of its core markets and steady alternative revenue growth, UBS Securities said in a research note last week.&nbsp;The company benefited from a traffic surge driven by more events in Q3, as well as sustained e-commerce momentum from its advertising growth and marketplace expansion, the research firm said, while reiterating its ‘Buy’ rating on the company’s shares.Bank of America analysts said this month that Walmart’s advertising momentum, along with easing pressure from general liability claims, should help support margins. The firm also noted two months ago that Walmart is emerging as a leader in applying artificial intelligence within the retail sector.Oppenheimer analysts said that strength in Walmart’s non-core businesses could prompt the retailer to raise its 2026 outlook, likely by increasing only the lower end of its EPS range.<h2 class="st-heading-2">Consensus View</h2>Analysts expect Walmart’s third-quarter revenue to increase 4.3% to $175.17 billion, according to Koyfin. At that level, it would be the fifth time in the last six quarters that year-over-year topline growth is below 5%. The Q4 growth projection is 4.5%.Adjusted earnings per share (EPS) are expected to increase by 3.7% to $0.60.Adjusted earnings before interest and tax (EBIT) margin is expected to be 4.07%, the lowest in the last four quarters, but above the 3.99% in Q3 last year.&nbsp;The results would follow a critical leadership announcement: Walmart announced last week that John Furner, the CEO of Walmart’s U.S. business, will succeed longtime CEO Doug McMillon in February.<h2 class="st-heading-2">WMT Share Trend</h2>Walmart’s shares hit an all-time high after it announced a partnership with OpenAI that lets users shop Walmart products directly from ChatGPT. They have since declined by about 8%.In a tumultuous year, particularly for retailers, the WMT stock has emerged resilient. WMT is up 11.4% year-to-date, compared to the 13% gains in the benchmark S&amp;P 500. In comparison, Dollar General’s stock is up over 30%, while Costco’s shares are in the red.On Stocktwits, the retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/WMT">WMT</a> shifted to ‘bullish’ as of early Thursday, from ‘bearish’ the previous day.<figure class="image"><img style="aspect-ratio:638/70;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_20_at_12_26_16_PM_png_586f828621.webp" alt="Screenshot 2025-11-20 at 12.26.16 PM.png" width="638" height="70"><figcaption>WMT sentiment and message volume as of November 20 | Source: Stocktwits</figcaption></figure>“$WMT With&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-torches-ai-bubble-talk-with-blowout-q3/cLPqCIORE9c">NVDA lifting the market sentiment</a>, tomorrow would be a great day if WMT reports good numbers. With good numbers and positive outlook I smell $110 (or) else $90,” said a user.<stembedurl>https://stocktwits.com/killbilltrader/message/636829450</stembedurl><h2 class="st-heading-2">Peer Retailers’ Results Show Consumer Hunting For Value</h2>Rival Target on Wednesday posted a drop in third-quarter sales and lowered its full-year profit guidance, citing choppy spending with shoppers hunting for value.It stuck to its sales forecast for the all-important holiday quarter, expecting a low-single-digit percentage decline compared to Q4 last year. Target is planning a bigger push on new stores and remodels next year, with an outlay of $1 billion.Home improvement goods retailers Home Depot and Lowe’s Companies also cut their annual profit forecasts after posting mixed results earlier this week.On the other hand, TJX Cos., which operates discount chains T.J. Maxx, HomeGoods, and Marshalls, raised its FY26 sales and profit forecasts, betting that its value items and a fresh seasonal assortment will drive holiday-season sales.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/weshop-stock-gains-over-6-fold-days-after-direct-listing-retail-ecstatic/cLPA3WHRE9O">WeShop Stock Gains Over 6-Fold, Days After Direct Listing: Retail Ecstatic</a>

A Walmart logo seen displayed on a smartphone screen, with a stock chart in the background. The retail chain is reporting Q3 results on Thursday during the premarket hours.(Photo Illustration by Mateusz Slodkowski/SOPA Images/LightRocket via Getty Images)

Walmart Heads For ‘Clean’ Q3 Print; Margins, Holiday Quarter Forecast In Focus, Analysts Upbeat On Digital Push

The Wall Street expect Walmart to report a 4.3% increase in sales and a 3.7% rise in adjusted EPS for the third quarter, with some analysts a slight upward revision to the annual forecast.

Stay Ahead of Market Turmoil With These ETFs

With stocks sliding, volatility spiking and bubble concerns mounting, investors need a defensive game plan. These ETFs can help you navigate the turbulence.

$1 Trillion Holiday Season Sales Haul: ETFs to Gain Momentum

With U.S. holiday sales set to surpass $1 trillion, ETFs like RTH, EBIZ, and VDC could shine as retail spending surges. 

Don't Forget Defensive ETFs Even as Market Optimism Builds

As market optimism builds, investors may want to fortify portfolios with defensive ETFs like VTV, XLP and QUAL to weather potential volatility.

<ul class="summary-bullets"><li>Last week, Mizuho reduced the stock's price target to $1.50 from $2 and maintained a ‘Sell’ rating.</li><li>For the year, Beyond Meta stock has slumped 42%, contrasting with the record levels of the broader S&amp;P 500 Index.</li><li>Stocktwits users have been optimistic about the stock despite its volatility.</li></ul>Beyond Meat, Inc. (BYND) stock has been on a volatile ride since early October, earning meme status, and it appears on track to open sharply lower in Monday’s session.In overnight trading,&nbsp;<a href="https://stocktwits.com/symbol/BYND">Beyond Meat stock</a> is down nearly 15%, according to Yahoo Finance.&nbsp;<h2 class="st-heading-2">Beyond Meat’s Rally &amp; Retreat</h2>Shares of Beyond Meat, a maker of plant-based meat, plunged 23% on Friday, defying the broader market rally. The downside trigger was a commentary from Mizuho analyst Baumgartner that the stock would suffer from significant equity dilution following the conversion of the senior notes due 2027, according to the Fly. The analyst reduced the stock's price target to $1.50 from $2 and maintained a ‘Sell’ rating, citing the company’s weak market position and fundamentals, the Fly reported.The company announced on Thursday that the lock-up restrictions on certain of the 316.15 million shares issued on Oct. 15 in connection with the note offering would expire at 5 p.m. ET that day.Separately, in an 8-K filing, Beyond Meat disclosed preliminary results for the September quarter, expecting revenue of about $70 million compared to the guidance of $68 million to $73 million and the Fiscal.ai-compiled consensus of $69.79 million.&nbsp; The company expects a gross margin of 10%-11%, including $1.7 million in expenses related to suspending China operations. The company also flagged a non-cash impairment charge related to certain of its long-lived assets that haven’t been included in the preliminary numbers.On Thursday, Beyond Meat’s stock plunged about 21% as traders took profit after a strong two-day rally. The recent downtrend followed a substantial two-day advance. Beyond Meat stock jumped about 128% on Monday and then surged another 146% on Tuesday. Much of the buoyancy in the El Segundo, California-based company’s stock was due to the distribution agreement it clinched with Walmart. It also announced the debut of its latest iterations of its Beyond Burger and Beyond Beef at Erewhon locations.<img src="https://news.stocktwits-cdn.com/Beyond_Meat_YTD_Chart_png_48e87f8b4e.webp" alt="Beyond Meat YTD Chart.png">Chart courtesy of Koyin<h2 class="st-heading-2">What Retail’s Saying About Beyond Meat Stock</h2>Stocktwits users have been optimistic about the stock despite its volatility. Retail sentiment toward Beyond Meat stock has largely been ‘extremely bullish’ for about three months now. The message volume on the stream has also been at ‘extremely high’ levels.A bullish user said that short covering creates inevitable demand. “Our strategy stays crystal clear: buy, hold, and rocket the squeeze to Mars!” they said. According to Koyfin, the stock's short interest is a whopping 51.60%.<stembedurl>https://stocktwits.com/PureLand/message/633785003</stembedurl>Another user sounded positive about the company’s products being at big retail stores, including Walmart, Costco, Target, Safeway, Aldi, Whole Foods, and Sprouts.<stembedurl>https://stocktwits.com/Houndify/message/633784846</stembedurl>For the year, Beyond Meta stock has slumped 42%, contrasting with the record levels of the broader S&amp;P 500 Index. During the same period, the<a href="https://stocktwits.com/symbol/IYK"> iShares US Consumer Staples ETF (IYK)</a> has gained 7.25%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/meta-faces-rising-china-challenge-as-alibaba-xiaomi-join-ai-smartglasses-race-goldman-sees-supply-chain-winners/cLGiHYFR3ty">Meta Faces Rising China Challenge As Alibaba, Xiaomi Join AI Smartglasses Race: Goldman Sees Supply Chain Winners</a>

 Beyond Meat products are shown on February 29, 2024 in Chicago, Illinois. 

Beyond Meat Stock Set Another Big Drop, But Retail Traders Keep Faith In This Meme Name

For the year, Beyond Meta (BYND) stock has slumped 42%, contrasting with the record levels of the broader S&P 500 Index.

Beyond Meat (BYND) Stock Set Another Big Drop, But Retail Traders Keep Faith In This Meme Name

A $38 Trillion Problem: ETFs to Play Rising Debt Pressure

With U.S. debt hitting a record $38 trillion amid a prolonged shutdown, investors should turn to defensive ETF strategies for stability.

Coke & Pepsi Earnings to Lift Consumer Staples ETFs?

Coke (KO) & Pepsi (PEP) posted strong earnings, sparking likely gains in consumer staples ETFs like XLP, FSTA & VDC.


Feeling Tech-Heavy? Diversify With These ETFs Amid AI Bubble Concerns

Wall Street warns of an AI equity bubble as mega-cap tech surges, prompting investors to diversify into ETFs for balanced growth.

VDC
Vanguard Consumer Staples ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VDC News

VDCVanguard Consumer Staples ETF